Patrick Daugherty and Denny Carter break down how quarterback Andy Dalton could mesh with Carolina Panthers head coach Dave ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...

The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

The pro dancer also previews her partnership with Joey Graziadei, saying the Bachelor is 'humble and hardworking.' ...

Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Antiphospholipid Syndrome.

In a report released today, Larry Biegelsen from Wells Fargo maintained a Hold rating on Johnson & Johnson (JNJ – Research Report).

Erdafitinib is under clinical development by Johnson & Johnson and currently in Phase II for Soft Tissue Sarcoma.

Today, we are looking at leisure products stocks, starting with Johnson Outdoors (NASDAQ:JOUT). Leisure products cover a wide range of goods in the consumer discretionary sector. Maintaining a ...

The Biden administration’s drug-price negotiation law threatens new product development and will lead to fewer new medicines ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...